Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Free heme and hemozoin intermediates are central components of the heme detoxification pathway in the digestive vacuole of Plasmodium falciparum (Sullivan, 2002, PMID: 12456505). During its lifecycle within human red blood cells, the parasite digests host hemoglobin, releasing ferriprotoporphyrin IX (free heme), which is toxic due to its ability to generate reactive oxygen species and disrupt lipid membranes (Egan, 2008, PMID: 18601567). To mitigate this toxicity, the parasite converts free heme into an insoluble, chemically inert crystalline form called hemozoin, also known as malaria pigment (Pagola et al., 2000, PMID: 10716456). This biocrystallization process is a validated therapeutic target; drugs such as chloroquine and quinine interfere with the formation of hemozoin by binding to heme or the crystal surface (Hempelmann, 2007, PMID: 17343618). The resulting accumulation of toxic heme intermediates leads to the destruction of the parasite's internal membranes and eventual cell death. Despite the emergence of resistance, targeting heme sequestration remains a cornerstone of antimalarial pharmacology.
Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic free heme (ferriprotoporphyrin IX) which causes oxidative stress and membrane damage within the parasite digestive vacuole.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Free heme and hemozoin intermediates.